ArticleNature medicine2026

Oral small-molecule GLP-1RA safiglipron versus dapagliflozin in type 2 diabetes: a randomized, double-blind, active-comparator-controlled phase 3 trial.

Lixin Guo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.